MediLink Therapeutics (Suzhou) Co., Ltd.
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
MediLink Therapeutics closes $50 million Series A financing
MediLink Therapeutics announced that it had closed a $50 million Series A financing, with a Series-A1 round led by Apricot Capital and a Series-A2 round co-led by Loyal Valley Capital and Qiming Venture Partners.